Octreotide-Resistant Acromegaly: Challenges and Solutions
Giuliana Corica,1,2 Marco Ceraudo,3 Claudia Campana,1,2 Federica Nista,1,2 Francesco Cocchiara,2 Mara Boschetti,1,2 Gianluigi Zona,3 Diego Criminelli,3 Diego Ferone,1,2 Federico Gatto1 1Endocrinology Unit, IRCCS Ospedale Policlinico San Martino, Genoa, Italy; 2Endocrinology Unit, Department of Inter...
Guardado en:
Autores principales: | Corica G, Ceraudo M, Campana C, Nista F, Cocchiara F, Boschetti M, Zona G, Criminelli D, Ferone D, Gatto F |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/ee2058b7659e43818d561f56127b650c |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
The place of medical treatment of acromegaly in Serbia: Current status
por: Doknić Mirjana, et al.
Publicado: (2021) -
Features of carbohydrate metabolism and incretin secretion in patients with Cushing disease and acromegaly
por: Lubov V. Matchekhina, et al.
Publicado: (2017) -
Postoperative GH and Degree of Reduction in IGF-1 Predicts Postoperative Hormonal Remission in Acromegaly
por: Tyler Cardinal, et al.
Publicado: (2021) -
Targeted paclitaxel‐octreotide conjugates inhibited the growth of paclitaxel‐resistant human non‐small cell lung cancer A549 cells in vitro
por: Yanguo Liu, et al.
Publicado: (2021) -
Somatostatin and Its Receptors in Myocardial Ischemia/Reperfusion Injury and Cardioprotection
por: Imre Vörös, et al.
Publicado: (2021)